Bertrand Bodson explains the Novartis strategy for digital innovation in asthma care.

Hundreds of millions of people worldwide await treatments for rare diseases.

Van der Kamp explains how leading by example has encouraged others to adopt flexible working models.

Gschwentner and Lackner discuss the advantages of their job share.

The culture of volunteerism is a fundamental part of the Novartis corporate ethos. Here’s a snapshot of our efforts over the years.

On Friday nights, Juan Pedro García Hernández goes dancing – but for rest of the time he’s taking care of his mother.

Patients with glaucoma, which affects 60 million people worldwide, can lose up to 40 percent of their sight before they begin to notice any change in vision.

For patients with lung cancer, biomarker testing may be an option.

Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.

Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.